Amprius Technologies Inc (AMPX) stock analysis: A comprehensive overview

While Amprius Technologies Inc has underperformed by -0.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMPX rose by 245.87%, with highs and lows ranging from $4.27 to $0.61, whereas the simple moving average jumped by 65.76% in the last 200 days.

On January 21, 2025, Cantor Fitzgerald started tracking Amprius Technologies Inc (NYSE: AMPX) recommending Overweight. A report published by ROTH MKM on January 11, 2024, Initiated its previous ‘Buy’ rating for AMPX. Alliance Global Partners Initiated an Buy rating on December 05, 2023, and assigned a price target of $10. H.C. Wainwright initiated its ‘Buy’ rating for AMPX, as published in its report on October 31, 2023. Northland Capital’s report from June 02, 2023 suggests a price prediction of $16 for AMPX shares, giving the stock a ‘Outperform’ rating. B. Riley Securities also rated the stock as ‘Buy’.

Analysis of Amprius Technologies Inc (AMPX)

Further, the quarter-over-quarter increase in sales is 383.05%, showing a positive trend in the upcoming months.

Amprius Technologies Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -68.88% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.45, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and AMPX has an average volume of 3.70M. On a monthly basis, the volatility of the stock is set at 6.25%, whereas on a weekly basis, it is put at 5.96%, with a gain of 12.87% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.50, showing growth from the present price of $3.77, which can serve as yet another indication of whether AMPX is worth investing in or should be passed over.

How Do You Analyze Amprius Technologies Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 28.34%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 17.05% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

AMPX shares are owned by institutional investors to the tune of 17.05% at present.

Hot this week

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

Topics

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

A stock that deserves closer examination: Perpetua Resources Corp (PPTA)

While Perpetua Resources Corp has overperformed by 2.68%, investors...

Perspective Therapeutics Inc (CATX) deserves deeper analysis

While Perspective Therapeutics Inc has underperformed by -2.27%, investors...

Was Foremost Clean Energy Ltd (FMST)’s session last reading good?

While Foremost Clean Energy Ltd has overperformed by 2.80%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.